US Patent Issued to GEORG-AUGUST-UNIVERSITAT GOTTINGEN STIFTUNG OFFENTLICHEN RECHTS, UNIVERSITATSMEDIZIN, LIFEARC on May 13 for "Humanised anti-n-truncated amyloid Beta monoclonal antibody" (British, German Inventors)

ALEXANDRIA, Va., June 12 -- United States Patent no. 12,297,261, issued on May 13, was assigned to GEORG-AUGUST-UNIVERSITAT GOTTINGEN STIFTUNG OFFENTLICHEN RECHTS, UNIVERSITATSMEDIZIN (Gottingen, Germany) and LIFEARC (London).

"Humanised anti-n-truncated amyloid Beta monoclonal antibody" was invented by Thomas Bayer (Gottingen, Germany), Preeti Bakrania (Harrow, Great Britain), Sarah Davies (Stevenage, Great Britain), Alex Brown (Chesham, Great Britain), Chido Mpamhanga (Harpenden, Great Britain), David Matthews (Hitchin, Great Britain), Mark Carr (Leicester, Great Britain) and Gareth Hall (Leicester, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to humanised anti...